scPharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Scpharmaceuticals

15/08/2024 05:10

* scPharmaceuticals Inc  SCPH.OQ  reported a quarterly
adjusted
loss of 44 cents​​ per share for the quarter ended in June,
lower than the same quarter last year, when the company reported
EPS of -36 cents.  The mean expectation of six analysts for the
quarter was for a loss of 41 cents per share. Wall Street
expected results to range from -47 cents to -35 cents per share.
    * Revenue rose 391.7% to $8.05 million from a year ago;
analysts
expected $7.97 million. 
    * scPharmaceuticals Inc's reported EPS for the quarter was a
loss
of 44 cents​.
    * The company reported a quarterly loss of $17.09 million.
    * scPharmaceuticals Inc shares had risen by 13.3% this
quarter and
lost 21.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for scPharmaceuticals
Inc is $19.00 
This summary was machine generated from LSEG data August 15 at
04:10 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.41          -0.44          Missed
 Mar. 31 2024      -0.44          -0.36          Beat
 Dec. 31 2023      -0.42          -0.35          Beat
 Sep. 30 2023      -0.36          -0.41          Missed